Subsite‐specific trends in mid‐ and long‐term survival for head and neck cancer patients in Japan: A population‐based study

Abstract

Advances in diagnostic techniques and treatment modalities have impacted head and neck cancer (HNC) prognosis, but their effects on subsite‐specific prognosis remain unclear. This study aimed to assess subsite‐specific trends in mid‐ and long‐term survival for HNC patients diagnosed from 1993 to 2011 using data from population‐based cancer registries in Japan. We estimated the net survival (NS) for HNC by subsite using data from 13 prefectural population‐based cancer registries in Japan. Changes in survival over time were assessed by multivariate excess hazard model of mortality. In total, 68,312 HNC patients were included in this analysis. We observed an overall improvement in 5‐year NS for HNC patients in Japan. However, survival varied among subsites of HNC, with some, such as naso‐, oro‐ and hypopharyngeal cancers, showing significant improvement in both 5‐ and 10‐year NS, whereas others such as laryngeal cancer showed only a slight improvement in 5‐year NS and no significant change in 10‐year NS after adjustment for age, sex and stage. In conclusion, the study provides insights into changing HNC survival by site at the population level in Japan. Although advances in diagnostic techniques and treatment modalities have improved survival, these improvements are not shared equally among subsites.

Abstract

We evaluated trends of head and neck cancer survival by subsite in Japan using population‐basedcancer registry data. During the observation periods, each pharyngeal cancer showed an upward trend, although laryngeal cancer showed no significant trend in long‐term survival. These findings may reflect the change in mainstream treatment.